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Background
• MA are generally healthier overall than population peers 
• 8 of 9 chronic conditions  prevalence vs Aus population (Halar et al, 2019 in prep)
• Supplement use is common in athletes (40-100%; Garthe et al, IJSNEM 2018)
• ~60-62% in masters athletes (Striegel et al, IJSM 2006; Guthrie et al, IJSNEM 2016)
• Prevalence of concurrent prescription drug use and medicinal 
herbal medicines in older people varies (Agbabiaka et al, Drugs Aging 2017)
• Athletes, athlete support personnel, others participating in activities 
of the International Masters Games Association (IMGA) - bound by 
IMGA Anti-Doping Rules (approved by WADA 2015, IMGA 2016)
90 year old Heather Lee broke the 
world record for the 3000m walk at 
the AMG 2017*
www.australianmastersgames.com/ne
ws
Tartans Crème Puffs 2017*
:tartanshockey.org.au
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Aim
Describe the prevalence of medication and supplement use for 
treatment of chronic conditions, and dietary supplement/sports 
food use in masters athletes
Prohibitions of medications used and potential for interactions were also 
investigated.
AMG Dragon Boat participants, Lake 
Barrington (with permission)
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Methods
• 2017 AMG: n=4848, 2018 PPMG: n=14456
• anonymous online survey (10-20 mins)
University of Sydney Human Ethics Committee (Project No. 2017/592)
AMG participant filling out 
survey (with permission)
AMG e-news 29/9/17
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Methods
• demographics, health conditions, treatment methods, dietary 
supplements/sports foods (DSSF) collected
• representativeness: Pearson's Chi-squared, Kruskal-Wallis rank sum test
• medications/supplements (including herbal) treatments doubly extracted
• medications prohibitions categorised – international standards e.g. WADA
• dietary supplements and sports foods collated 
• single ingredient/branded dietary supplements checked for interactions
• measures to ensure supplement safety collated
University of Sydney Human Ethics Committee (Project No. 2017/592)
Image source: 
https://www.caresearch.com.au/Caresearch/Port
als/0/Nurses%20Hub/Evidence%20Based%20P
ractice.jpg
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Results
• n=817 (53.7±14.0 yrs, 60.8% F) 
• 84.7% (n=692) Aus, 9.4% (n=77) NZ
• vs all MG participants (p<0.001): 
•  age
• <20-39yo, >60+
•  F
• Australian residency similar
• Top ten sports similar
25.7%
24.0%
19.1%
20.3%
10.9%
1 year or
less
2-5 years 6-10
years
11-20
years
20 years
or more
Competing length (years)
Years competing at masters level
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Results
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• Medical conditions
• 48.1% (n=393) with current 
condition
• 25.3% (n=206) took medications
• 7.1% (n=58) used 
supplements/herbal therapies
• Medications
• Asthma (26.6% usages): Ventolin, 
Seretide, others
• Heart/Circ (23.4% usages): 
Telmisartan, Perindopril, Rosuvastatin, 
others
• Supplements
• Arthritis/bone (64.1% usages): 
glucosamine, turmeric, vitamin D, 
calcium
• Obesity (22.8% usages): shakes, 
vitamins/minerals
*does not include cancer or obesity (therapy for obesity not collected in AMG, medications for 
obesity not collected PPMG)
**one person could nominate more than one therapy
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Results
• 46.5% (n=380) used 1-16 DSSF
Types of supplements used by masters athletes
Carnitine, -alanine, 
beetroot juice, exotic 
berries, bicarbonate, 
quercetin, tart cherries, 
HMB
Chondroitin 
sulphate, Vitamin E
Sports confectionary
The University of Sydney Page 9
Results
• Potential prohibitions
• n=81 individuals (106 usages)
• -2 agonists (n=52), Glucocorticoids (n=34), 
combination (n=2)
• asthma, low BP, rapid/irregular heart beat
• -blockers (n=6)
• hypertension, heart failure, rapid/irregular heart beat, 
other heart condition
• Diuretics/masking agents (n=4)
• fluid retention, heart failure
• Hormone/metabolic modulators (n=5)
• diabetes, obesity
• Stimulant (n=1)
• obesity
• Interactions
• 46.3% used 2 therapies/DSSF
• 2.1% known interaction
• e.g. fish oils + antihypertensives, 
creatine + nephrotoxic drugs, 
glucosamine + warfarin* 
Therapeutic Research Centre. Natural Medicines. Available from: 
https://naturalmedicines.therapeuticresearch.com. [Accessed 8 June 2019]. 
The University of Sydney Page 10
Results
• Potential prohibitions
• n=81 individuals (106 usages)
• -2 agonists (n=52), Glucocorticoids (n=34), 
combination (n=2)
• asthma, low BP, rapid/irregular heart beat
• -blockers (n=6)
• hypertension, heart failure, rapid/irregular heart beat, 
other heart condition
• Diuretics/masking agents (n=4)
• fluid retention, heart failure
• Hormone/metabolic modulators (n=5)
• diabetes, obesity
• Stimulant (n=1)
• obesity
• Interactions
• 46.3% used 2 therapies
• 2.1% known interaction
• e.g. fish oils + antihypertensives, 
creatine + nephrotic drugs, 
glucosamine + warfarin*
Therapeutic Research Centre. Natural Medicines. Available from: 
https://naturalmedicines.therapeuticresearch.com. [Accessed 8 June 2019]. 
The University of Sydney Page 11
Results
Measures taken to ensure supplement safety*
0 20 40 60 80 100 120 140
 Recommendation of Health/Sport professional
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Recommendation of Supplement Company
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Dont Know
3rd party testing
I Use an App
Number of people
*athletes could nominate more than one option
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– Internet platform (may also be a strength)
– Acute medication use not captured
– Interactions: multi-ingredient supplements difficult, did not check drug-to-drug
– Not possible to link safety checking methods with individual supplements
– Generalisability
– AMG recruitment on site as well as electronically  different sports?
– PPMG dataset on all participants was limited  limit demographic comparisons
– majority Australian
– Under-represented in younger age groups, over-representation of females 
influence consumption of supplements (types/numbers) and medications
Limitations
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Conclusions and implications
– Potential for misuse of supplements
– supplements may interact with medications 
– possibility of doping violations
– may not use appropriate measures to check safety
– MA likely to use supplements in combinations
– performance supplements used with other supplements (Gifford et al, ECSS 2018)
– multiple nutrition supplements may exceed upper limits
AMG Badminton, Burnie
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Conclusions and implications
– Medication/supplement for treatment and DSSF use is common 
among MA
– Many inexperienced MA may not be aware of the issues
– Health professionals 
– be pro-active in asking about medication and supplement use
– need to be aware of risks – doping violations, adverse interactions/effects
http://esheninger.blogspot.com/2013/11/leading-in-digital-age.html
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